Auris Medical Announces Acquisition of RNA Therapeutics Company and Plans for Strategic Repositioning Entering field of RNA therapeutics through acquisition of Trasir Therapeutics, Inc.Trasir’s innovative peptide-based OligoPhoreTM platform designed to enable extrahepatic delivery of...